Literature DB >> 7234389

Amphetamine addiction and pregnancy. III. One year follow-up of the children. Psychosocial and pediatric aspects.

L Billing, M Eriksson, G Larsson, R Zetterström.   

Abstract

Sixty-six infants born to amphetamine-addicted mothers were followed during their first year of life. The children were divided into three groups, according to whether or not the mother stopped her abuse in early pregnancy (Group I) or continued (Group II) and whether or not the latter children were placed in foster homes immediately after birth (Group III). All but 2 of 16 mothers in Group I stayed off drugs and mostly met non-addicted friends. In Group II, on the contrary, all but 2 of 36 mothers continued their abuse one year after delivery. At the age of one year, all but one child in Group I were in their mothers' custody and all children in Group III had remained in foster care. In Group II one-third of the children lived in foster homes after revocation of the maternal custody. Several infants in Group II had experienced multiple transfers between the biological home and different foster homes. There were indicators that maternal amphetamine abuse causes temporary drowsiness in the infants during the first months after birth. However, all children at the age of 12 months, regardless of group, had a somatic and psychomotor development in accordance with the normal Swedish standard. In all groups there was an increased rate of medical care mainly because of infections. Some infants in Group II compared to none in Groups I and III were hospitalized because of failure to thrive or suspected physical abuse. Symptoms indicating emotional disturbance were more common in infants of Group II than in infants of Groups I and III.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7234389     DOI: 10.1111/j.1651-2227.1980.tb07342.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  16 in total

1.  Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Amelia M Arria; Chris Derauf; Linda L Lagasse; Penny Grant; Rizwan Shah; Lynne Smith; William Haning; Marilyn Huestis; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry Lester
Journal:  Matern Child Health J       Date:  2006-01-05

Review 2.  Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.

Authors:  Maja A Kwiatkowski; Annerine Roos; Dan J Stein; Kevin G F Thomas; Kirsty Donald
Journal:  Metab Brain Dis       Date:  2013-12-28       Impact factor: 3.584

Review 3.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

4.  Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.

Authors:  Trecia A Wouldes; Linda L Lagasse; Marilyn A Huestis; Sheri Dellagrotta; Lynne M Dansereau; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2014-02-22       Impact factor: 3.763

5.  Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age.

Authors:  Linda L LaGasse; Chris Derauf; Lynne M Smith; Elana Newman; Rizwan Shah; Charles Neal; Amelia Arria; Marilyn A Huestis; Sheri DellaGrotta; Hai Lin; Lynne M Dansereau; Barry M Lester
Journal:  Pediatrics       Date:  2012-03-19       Impact factor: 7.124

6.  Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study.

Authors:  Zeina N Kiblawi; Lynne M Smith; Sabrina D Diaz; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri DellaGrotta; Lynne M Dansereau; Charles Neal; Barry Lester
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

7.  Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.

Authors:  Beau Abar; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne M Smith; Amelia Arria; Marilyn Huestis; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  Psychol Addict Behav       Date:  2012-10-15

Review 8.  Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Lynne M Smith; Sabrina Diaz; Linda L LaGasse; Trecia Wouldes; Chris Derauf; Elana Newman; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2015-07-23       Impact factor: 3.763

9.  Amphetamine secretion in breast milk.

Authors:  E Steiner; T Villén; M Hallberg; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Authors:  Lynne M Smith; Linda L Lagasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Melissa Fallone; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2007-10-03       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.